Lord, Abbett & Co
CRNX icon

Lord, Abbett & Co’s Crinetics Pharmaceuticals CRNX Stock Holding History

Lord, Abbett & Co’s Portfolio CRNX Stock Details CRNX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
2024
Q4 		$37M Sell
2024
Q3 		$38.1M Sell
2024
Q2 		$39.8M Sell
2024
Q1 		$45.2M Buy
2023
Q4 		$27.7M Buy